Insider trading

Period: 12 months Stock: NTRA Type of trade: Sold × Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

79 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

79 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

79 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

79 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
79 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
79 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

79 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
1 Oct 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$1.24M 3,000 at 414.22
2.7%
Planned (10b5-1)
15 Sep 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 13×
$17.36M 50,000 at 347.19
2.3%
Planned (10b5-1)
15 Sep 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold on a plan
$700.01K 2,000 at 350.01
100%
Sold half or more
14 Sep 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 15×
$16.74M 50,000 at 334.76
2.2%
Planned (10b5-1)
11 Sep 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 6×
$16.40M 50,000 at 327.97
2.2%
Planned (10b5-1)
2 Sep 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$4.96M 15,160 at 326.89
12.0%
Planned (10b5-1)
1 Sep 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$962.19K 3,000 at 320.73
2.3%
Planned (10b5-1)
10 Aug 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$2.10M 6,517 at 321.53
3.2%
Planned (10b5-1)
7 Aug 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold on a plan
$641.80K 2,000 at 320.90
50.0%
Sold half or more
3 Aug 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 7×
$905.63K 3,410 at 265.58
2.6%
Planned (10b5-1)
3 Aug 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$195.90K 731 at 267.99
0.0%
Planned (10b5-1)
3 Aug 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$89.51K 334 at 267.99
0.2%
Planned (10b5-1)
3 Aug 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$79.06K 295 at 267.99
0.2%
Planned (10b5-1)
28 Jul 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$305.90K 1,204 at 254.07
0.9%
Planned (10b5-1)
28 Jul 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$254.83K 1,003 at 254.07
0.6%
Planned (10b5-1)
28 Jul 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$236.54K 931 at 254.07
0.5%
Planned (10b5-1)
27 Jul 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$447.52K 1,718 at 260.49
0.1%
Planned (10b5-1)
27 Jul 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$263.10K 1,010 at 260.49
0.8%
Planned (10b5-1)
27 Jul 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$230.27K 884 at 260.49
0.5%
Planned (10b5-1)
27 Jul 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$203.70K 782 at 260.49
0.4%
Planned (10b5-1)
6 Jul 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN · indirect
Sold on a plan
$280.00K 1,000 at 280.00
20.0%
Planned (10b5-1)
1 Jul 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 12×
$4.57M 16,800 at 272.29
8.9%
Planned (10b5-1)
1 Jul 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$818.71K 3,000 at 272.90
2.2%
Planned (10b5-1)
24 Jun 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 4×
$8.46M 33,600 at 251.65
15.1%
Planned (10b5-1)
15 Jun 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 10×
$10.75M 50,000 at 214.91
2.1%
Planned (10b5-1)
12 Jun 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 11×
$10.70M 50,000 at 214.03
2.1%
Planned (10b5-1)
1 Jun 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 4×
$655.29K 3,000 at 218.43
2.1%
Planned (10b5-1)
26 May 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$335.09K 1,652 at 202.84
1.2%
Planned (10b5-1)
26 May 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$291.68K 1,438 at 202.84
0.8%
Planned (10b5-1)
5 May 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 4×
$1.49M 6,986 at 213.77
0.3%
Planned (10b5-1)
4 May 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$148.85K 722 at 206.16
0.0%
Planned (10b5-1)
1 May 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 7×
$693.56K 3,405 at 203.69
2.3%
Planned (10b5-1)
1 May 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$68.03K 330 at 206.16
0.1%
Planned (10b5-1)
1 May 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$59.99K 291 at 206.16
0.2%
Planned (10b5-1)
27 Apr 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 2×
$445.34K 2,182 at 204.10
1.5%
Planned (10b5-1)
27 Apr 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 2×
$379.81K 1,861 at 204.09
0.8%
Planned (10b5-1)
27 Apr 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$344.52K 1,688 at 204.10
0.9%
Planned (10b5-1)
1 Apr 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 5×
$1.71M 8,400 at 203.31
3.6%
Planned (10b5-1)
1 Apr 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$606.90K 3,000 at 202.30
2.0%
Planned (10b5-1)
16 Mar 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 8×
$9.81M 50,000 at 196.28
2.1%
Planned (10b5-1)
13 Mar 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 5×
$14.18M 75,000 at 189.01
3.1%
Planned (10b5-1)
12 Mar 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 10×
$14.29M 75,000 at 190.59
3.1%
Planned (10b5-1)
10 Mar 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$356.21K 1,745 at 204.13
0.7%
Planned (10b5-1)
10 Mar 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$186.78K 915 at 204.13
0.6%
Planned (10b5-1)
10 Mar 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$144.32K 707 at 204.13
0.4%
Planned (10b5-1)
6 Mar 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 5×
$1.65M 8,398 at 196.08
3.5%
Planned (10b5-1)
2 Mar 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$599.55K 3,000 at 199.85
2.0%
Planned (10b5-1)
3 Feb 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$830.28K 3,594 at 231.02
2.0%
Planned (10b5-1)
3 Feb 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$378.23K 1,639 at 230.77
1.2%
Planned (10b5-1)
3 Feb 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$307.84K 1,334 at 230.77
0.6%
Planned (10b5-1)
Showing 1–50 of 79. Page 1 of 2 Older →